PT1038522E - Derivados enantiomericos anticonvulsivos de aminoacidos - Google Patents

Derivados enantiomericos anticonvulsivos de aminoacidos

Info

Publication number
PT1038522E
PT1038522E PT00109377T PT00109377T PT1038522E PT 1038522 E PT1038522 E PT 1038522E PT 00109377 T PT00109377 T PT 00109377T PT 00109377 T PT00109377 T PT 00109377T PT 1038522 E PT1038522 E PT 1038522E
Authority
PT
Portugal
Prior art keywords
anticonvulsives
amino acids
enantiomeric derivatives
animal
enantiomeric
Prior art date
Application number
PT00109377T
Other languages
English (en)
Portuguese (pt)
Inventor
Harold Kohn
Original Assignee
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21760388&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1038522(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Res Corp Technologies Inc filed Critical Res Corp Technologies Inc
Publication of PT1038522E publication Critical patent/PT1038522E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT00109377T 1996-03-15 1997-03-17 Derivados enantiomericos anticonvulsivos de aminoacidos PT1038522E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1352296P 1996-03-15 1996-03-15

Publications (1)

Publication Number Publication Date
PT1038522E true PT1038522E (pt) 2004-10-29

Family

ID=21760388

Family Applications (2)

Application Number Title Priority Date Filing Date
PT00109377T PT1038522E (pt) 1996-03-15 1997-03-17 Derivados enantiomericos anticonvulsivos de aminoacidos
PT97916897T PT888289E (pt) 1996-03-15 1997-03-17 Derivados enantiomericos de aminoacidos anticonvulsivos

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT97916897T PT888289E (pt) 1996-03-15 1997-03-17 Derivados enantiomericos de aminoacidos anticonvulsivos

Country Status (12)

Country Link
EP (2) EP1038522B1 (https=)
JP (1) JP3145414B2 (https=)
AT (2) ATE268169T1 (https=)
AU (1) AU718577B2 (https=)
CA (1) CA2248317C (https=)
DE (3) DE69729392T2 (https=)
DK (2) DK1038522T3 (https=)
ES (2) ES2218024T3 (https=)
FR (1) FR09C0006I2 (https=)
NL (1) NL300376I1 (https=)
PT (2) PT1038522E (https=)
WO (1) WO1997033861A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048899A (en) * 1997-03-17 2000-04-11 Research Corporation Tech., Inc. Anticonvulsant enantiomeric amino acid derivatives
EP1642889A1 (en) * 2004-10-02 2006-04-05 Schwarz Pharma Ag Improved synthesis scheme for lacosamide
EP1873527A1 (en) 2006-06-30 2008-01-02 Schwarz Pharma Ag Method for identifying CRMP modulators
US8093426B2 (en) * 2007-12-04 2012-01-10 Ranbaxy Laboratories Limited Intermediate compounds and their use in preparation of lacosamide
DE102008059155A1 (de) 2008-11-27 2010-06-02 Ratiopharm Gmbh Trockenverarbeitung und neue Formen von Lacosamid
WO2011015617A1 (en) 2009-08-06 2011-02-10 Medichem, S.A. Solid forms of an n-(phenylmethyl)propanamide derivative and processes of preparation
EP2480524A1 (en) * 2009-09-25 2012-08-01 Cadila Healthcare Limited Processes for the preparation of lacosamide and intermediates thereof
IT1398044B1 (it) * 2010-01-29 2013-02-07 Archimica Srl Processo per la preparazione della lacosamide
CA2788451A1 (en) 2010-02-08 2011-08-11 Natco Pharma Limited A process for the preparation of lacosamide
US8907132B2 (en) 2010-02-09 2014-12-09 Msn Laboratories Private Limited Process for preparing (R)-2-acetamido-N-benzyl-3-methoxy-propionamide
EP2399901A1 (en) 2010-06-23 2011-12-28 Archimica GmbH Intermediate for producing lacosamide and a process for its preparation and conversion to lacosamide
EP2621893A1 (en) 2010-10-01 2013-08-07 UCB Pharma GmbH Process for the preparation of amino acid derivatives
WO2012051551A1 (en) * 2010-10-15 2012-04-19 Nektar Therapeutics N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides
HUE031138T2 (en) 2010-10-19 2017-06-28 Euticals Gmbh A method of producing lacosamide
EP2468261A1 (en) 2010-12-02 2012-06-27 UCB Pharma GmbH Formulation of lacosamide
BR112013013525A2 (pt) 2010-12-02 2016-10-18 Ucb Pharma Gmbh formulação de liberação controlada sólida de lacosamida para administração oral, composição farmacêutica sólida, e, método para a prevenção, alívio e/ou tratamento de uma doença do sistema nervoso central
CN104771356A (zh) * 2014-01-09 2015-07-15 山东方明药业集团股份有限公司 一种拉科酰胺注射液及其制备方法
US11278634B1 (en) 2021-02-12 2022-03-22 Extrovis Ag Stable parenteral composition of lacosamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378729A (en) * 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
ATE62222T1 (de) * 1985-02-15 1991-04-15 Res Corp Technologies Inc Aminosaeure-derivate und ihre anwendung zur herstellung eines antikrampfmittels.

Also Published As

Publication number Publication date
EP0888289A1 (en) 1999-01-07
ES2157567T3 (es) 2001-08-16
FR09C0006I2 (fr) 2009-12-18
CA2248317A1 (en) 1997-09-18
DE69705210T2 (de) 2001-09-20
DE122009000010I2 (de) 2010-10-21
ES2218024T3 (es) 2004-11-16
DE69705210D1 (de) 2001-07-19
EP0888289B1 (en) 2001-06-13
ATE268169T1 (de) 2004-06-15
NL300376I1 (nl) 2009-05-06
EP1038522B1 (en) 2004-06-02
EP1038522A3 (en) 2003-01-15
AU2539497A (en) 1997-10-01
CA2248317C (en) 2003-12-02
JP3145414B2 (ja) 2001-03-12
DE122009000010I1 (de) 2009-05-20
EP1038522A2 (en) 2000-09-27
FR09C0006I1 (https=) 2009-04-17
ATE202079T1 (de) 2001-06-15
DK0888289T3 (da) 2001-09-03
JP2000505476A (ja) 2000-05-09
DE69729392T2 (de) 2005-06-02
DE69729392D1 (de) 2004-07-08
AU718577B2 (en) 2000-04-13
WO1997033861A1 (en) 1997-09-18
DK1038522T3 (da) 2004-10-11
PT888289E (pt) 2001-09-28

Similar Documents

Publication Publication Date Title
NL300376I1 (nl) Enantiomere anticonvulsieaminozuurderivaten
FI941378A0 (fi) Bentsimidatsoliyhdisteitä, niiden käyttö ja valmistus
NO924915D0 (no) Sakkarinderivater med inhiberende virkning paa protolytiske enzymer
EP0973719A4 (en) METHOD FOR PRODUCING AMINOCARBOXYLIC ACIDS
FI942310A0 (fi) 1,3-substituoidut sykloalkeenit ja sykloalkaanit keskushermostoon vaikuttavina aineina
ATE399545T1 (de) Mittel zur verringerung der eigeweidefette
TW287103B (https=)
EA199800189A1 (ru) Оптически активное производное фенилпиримидина в качестве анальгетика
EP1034783A4 (en) AMIDE DERIVATIVES
ATE264104T1 (de) Immunmodulierende arzneimittelzusammenstellung
DZ2619A1 (fr) Procédé pour la préparation d'acides 4-phényl-4-cyanocyclohexanoïques substitués.
EA199900888A1 (ru) Противоревматические средства
FI963568A0 (fi) Peptidijohdannaisia
DZ2423A1 (fr) Procédé pour la préparation d'acides 4-phényl-4-cyanocyclohexanoiques substitués.
DZ2757A1 (fr) Procédé pour la préparation d'acides hydroxamiques.
PL331407A1 (en) Method of treating bipolar disorders
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
EA200101043A1 (ru) Способ лечения неврологических или нейропсихиатрических расстройств
ES2133072A1 (es) Derivados de glicina n-sustituidos con actividad terapeutica sobre el sistema nervioso central.
FR2721020B1 (fr) Procédé de préparation d'alpha-amino-aldéhydes N-protégés.